piracetam has been researched along with Hematoma, Subdural in 2 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Hematoma, Subdural: Accumulation of blood in the SUBDURAL SPACE between the DURA MATER and the arachnoidal layer of the MENINGES. This condition primarily occurs over the surface of a CEREBRAL HEMISPHERE, but may develop in the spinal canal (HEMATOMA, SUBDURAL, SPINAL). Subdural hematoma can be classified as the acute or the chronic form, with immediate or delayed symptom onset, respectively. Symptoms may include loss of consciousness, severe HEADACHE, and deteriorating mental status.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam generally appears to have a similar efficacy to phenytoin in preventing clinical and/or electrographic seizures following acute/subacute SDH diagnosis, though patients with midline shift >0 mm may have associated with a higher risk of electrographic seizures on levetiracetam compared with patients on phenytoin." | 3.80 | Levetiracetam versus phenytoin: a comparison of efficacy of seizure prophylaxis and adverse event risk following acute or subacute subdural hematoma diagnosis. ( Chou, SH; Du, R; Lee, JW; Radic, JA, 2014) |
| " Prospective, open-label, steady-state pharmacokinetic study." | 2.76 | Steady-state pharmacokinetics of intravenous levetiracetam in neurocritical care patients. ( Fleck, JD; Jacobi, J; Juenke, JM; Kays, MB; Spencer, DD, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Radic, JA | 1 |
| Chou, SH | 1 |
| Du, R | 1 |
| Lee, JW | 1 |
| Spencer, DD | 1 |
| Jacobi, J | 1 |
| Juenke, JM | 1 |
| Fleck, JD | 1 |
| Kays, MB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pharmacokinetic Analysis of Levetiracetam Prophylaxis in Critically Ill Patients With Severe Traumatic Brain Injury[NCT04836481] | 20 participants (Anticipated) | Observational | 2021-01-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for piracetam and Hematoma, Subdural
| Article | Year |
|---|---|
Steady-state pharmacokinetics of intravenous levetiracetam in neurocritical care patients.
Topics: Anticonvulsants; Brain Injuries; Critical Care; Female; Hematoma, Subdural; Humans; Infusions, Intra | 2011 |
1 other study available for piracetam and Hematoma, Subdural
| Article | Year |
|---|---|
Levetiracetam versus phenytoin: a comparison of efficacy of seizure prophylaxis and adverse event risk following acute or subacute subdural hematoma diagnosis.
Topics: Aged; Anticonvulsants; Female; Hematoma, Subdural; Humans; Levetiracetam; Male; Middle Aged; Phenyto | 2014 |